Mariane Fraguas-Eggenschwiler
Has grant
Postdoctoral Researcher at Prof. Dr. Heiner Niemann's group
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
miR-29a targets two central components of active DNA demethylation, TET1 and TDG: potential mechanism during reprogramming
Open Date: 2014-01-01
Close Date: 2014-03-01
Grant: Close
Roles of microRNAs in molecular mechanisms modulation of reprogramming and pluripotency induction of somatic cells.
Open Date:
Close Date: 2014-11-01
Grant: Close
Direct hepatic differentiation of porcine (Sus scrofa) primary somatic cells as a model for chimeric liver generation
Open Date:
Close Date:
Articles (2)
Cas9–SpRY is an engineered variant of the Streptococcus pyogenes Cas9 with relaxed PAM recognition, which can technically be utilized at any target in the genome but some targets are addressed with low efficiency. Here, we show that a previously unexplored motif at the turn and beginning of α-helix 51 (TH51) can be engineered to improve both nuclease and prime-editing activity of Cas9–SpRY. Interaction of the lysine-rich PID loop 2 (PL2) with the target DNA downstream of the PAM (post-PAM) mediates initiation of R-loop formation and subsequent cleavage yet it was unclear if other regions of the PID engage with post-PAM as well. To this end, the NAAN–PAM-targeting iSpyMac hybrid nuclease, which lacks all lysine residues in PL2, was compared with Cas9–SpRY at identical targets using molecular dynamics simulation and in cell culture models, uncovering four crucial post-PAM-interacting lysines in TH51 and TH53 of iSpyMac. Ectopic insertion of a lysine-rich PL2 into iSpyMac boosted its nuclease and prime-editing activities and, in turn, Cas9–SpRY benefited from certain lysine-rich TH51 motifs. Specifically, TH51 from an uncultured Abiotrophia Cas9 species boosted overall Cas9–SpRY activity. Together, this study demonstrates that engineering of post-PAM interacting motifs opens new avenues for the design of advanced CRISPR enzymes.
Year:
2025
Year:
2021
Collaborators (1)
Tobias Cantz
Prof. of Translational Hepatology and Stem Cell Biology
Hannover Medical School
Make your next move.
Prepare your application
Review drafts before you send them.